Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Li, Zhaolong ^a,b   Yu, Jinghua ^a   Liu, Li ^a   Wei, Zhenhong ^a   Ehrlich, Elana S ^c   Liu, Guanchen ^a   Li, Jingliang ^a   Liu, Xin ^a   Wang, Hong ^a   Yu, Xiao Fang ^a,d   Zhang, Wenyan ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c TOWSON UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; PHOSPHATIDYLSERINE; CASPASE;

APOPTOSIS; ARTICLE; BRONCHOPNEUMONIA; CELLULAR DISTRIBUTION; CERVICAL CANCER CELL LINE; CHROMATIN CONDENSATION; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; CYTOPATHOGENIC EFFECT; DNA FRAGMENTATION; FEVER; GLIOBLASTOMA CELL LINE; HAND FOOT AND MOUTH DISEASE; HEK293 CELL LINE; HEPG2 CELL LINE; HERPANGINA; HUMAN; HUMAN CELL; IN VITRO STUDY; MYOCLONUS; NERVE CELL; NEUROBLASTOMA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; RASH; RHABDOMYOSARCOMA CELL LINE; VIRAL TROPISM; VIRUS REPLICATION; VIRUS STRAIN; VOMITING; CELL NUCLEUS; CHEMISTRY; COXSACKIE VIRUS INFECTION; ENTEROVIRUS; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; VIROLOGY;

COXSACKIEVIRUS;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; COXSACKIEVIRUS INFECTIONS; DNA FRAGMENTATION; ENTEROVIRUS; HEK293 CELLS; HEP G2 CELLS; HUMANS; NEURONS; PHOSPHATIDYLSERINES; VIRAL TROPISM;

EID: 84908577205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111174     Document Type: Article

References (47)

1. United States Centers for Disease Control and Prevention (1998) Deaths among children during an outbreak of hand, foot, and mouth disease-Taiwan, Republic of China, April-July 1998. MMWR Morb Mortal Wkly Rep 47: 629-632.
2. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, et al. (2000) Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31: 678-683.
3. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999) Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis 52: 12.
4. Ang LW, Koh BK, Chan KP, Chua LT, James L, et al. (2009) Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 38: 106-112.
5. Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, et al. (2009) Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 62: 254-259.
6. Li L, He Y, Yang H, Zhu J, Xu X, et al. (2005) Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 43: 3835-3839.
7. Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY (2003) Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 9: 291-293.
8. Podin Y, Gias EL, Ong F, Leong YW, Yee SF, et al. (2006) Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health 6: 180.
9. Li W, Yi L, Su J, Lu J, Zeng H, et al. (2013) Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China. BMC Infect Dis 13: 322.
10. Chong CY, Chan KP, Shah V, Ng W, Lau G, et al. (2003) Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatrica 92: 1163-1169.
11. Wang X, Zhu C, Bao W, Zhao K, Niu J, et al. (2012) Characterization of fulllength enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One 7: e32405.
12. Zeng M, Zheng X, Wei R, Zhang N, Zhu K, et al. (2013) The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis 7: e2599.
13. Zhang X, Wang H, Ding S, Wang X, Chen X, et al. (2013) Prevalence of enteroviruses in children with and without hand, foot, and mouth disease in China. BMC Infect Dis 13: 606.
14. Wang SM, Liu CC (2014) Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert Rev Anti Infect Ther 12: 447-456.
15. Huang PN, Shih SR (2014) Update on enterovirus 71 infection. Curr Opin Virol 5C: 98-104.
16. Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, et al. (2002) The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293: 386-395.
17. Chang SC, Lin JY, Lo LY, Li ML, Shih SR (2004) Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol 10: 338-349.
18. Xu LJ, Jiang T, Zhang FJ, Han JF, Liu J, et al. (2013) Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS One 8: e65948.
19. Lu JR, Lu WW, Lai JZ, Tsai FL, Wu SH, et al. (2013) Calcium flux and calpainmediated activation of the apoptosis-inducing factor contribute to enterovirus 71-induced apoptosis. J Gen Virol 94: 1477-1485.
20. Shi W, Li X, Hou X, Peng H, Jiang Q, et al. (2012) Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection. BMC Infect Dis 12: 327.
21. Yen FB, Chang LY, Kao CL, Lee PI, Chen CM, et al. (2009) Coxsackieviruses infection in northern Taiwan-epidemiology and clinical characteristics. J Microbiol Immunol Infect 42: 38-46.
22. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, et al. (2004) A mouseadapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78: 7916-7924.
23. Wright HT Jr, Landing BH, Lennette EH, McCallister RM (1963) Fatal infection in an infant associated with Coxsackie virus group A, type 16. N Engl J Med 268: 1041-1044.
24. Zhu G, Zheng Y, Zhang L, Shi Y, Li W, et al. (2013) Coxsackievirus A16 infection triggers apoptosis in RD cells by inducing ER stress. Biochem Biophys Res Commun 441: 856-861.
25. Saraste A, Arola A, Vuorinen T, Kyto V, Kallajoki M, et al. (2003) Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol 12: 255-262.
26. Shrestha B, Gottlieb D, Diamond MS (2003) Infection and injury of neurons by West Nile encephalitis virus. J Virol 77: 13203-13213.
27. Adams JM (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev 17: 2481-2495.
28. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
29. Martelli AM, Zweyer M, Ochs RL, Tazzari PL, Tabellini G, et al. (2001) Nuclear apoptotic changes: an overview. J Cell Biochem 82: 634-646.
30. Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296: 1635-1636.
31. Yu JH, Cui Q, Jiang YY, Yang W, Tashiro S, et al. (2007) Pseudolaric acid B induces apoptosis, senescence, and mitotic arrest in human breast cancer MCF- 7. Acta Pharmacol Sin 28: 1975-1983.
32. Nagata S, Golstein P (1995) The Fas death factor. Science 267: 1449-1456.
33. Lopez-Guerrero JA, Alonso M, Martin-Belmonte F, Carrasco L (2000) Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology 272: 250-256.
34. Li J, Chang J, Liu X, Yang J, Guo H, et al. (2014) Protection from Lethal Challenge in a Neonatal Mouse Model by Circulating Recombinant Form Coxsackievirus A16 Vaccine Candidates. J Gen Virol.
35. Wei W, Guo H, Li J, Ren S, Wei Z, et al. (2014) Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV-A16. PLoS One 9: e94746.
36. Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, et al. (1999) Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 18: 1092-1096.
37. Jia L, Zhao C, Zhang L, Li S, Zhang D, et al. (2011) Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16]. Zhongguo dang dai er ke za zhi= Chinese journal of contemporary pediatrics 13: 635.
38. Yang E, Zhao H, Zhang Y, Liu J, Liao Y, et al. (2012) A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B). Sci China Life Sci 55: 336-342.
39. Mao Q, Wang Y, Gao R, Shao J, Yao X, et al. (2012) A neonatal mouse model of coxsackievirus a16 for vaccine evaluation. J Virol 86: 11967-11976.
40. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, et al. (1999) Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354: 1682-1686.
41. Yang Z, Zhu Q, Li X, Wang X, Wang J, et al. (2005) [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002]. Zhonghua Er Ke Za Zhi 43: 648.
42. Fu Q, Duan X, Yan S, Wang L, Zhou Y, et al. (2013) Bioluminescence imaging of caspase-3 activity in mouse liver. Apoptosis 18: 998-1007.
43. Belov GA, Romanova LI, Tolskaya EA, Kolesnikova MS, Lazebnik YA, et al. (2003) The major apoptotic pathway activated and suppressed by poliovirus. J Virol 77: 45-56.
44. Brisac C, Teoule F, Autret A, Pelletier I, Colbere-Garapin F, et al. Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis. J Virol 84: 12226-12235.
45. Chackerian B, Long EM, Luciw PA, Overbaugh J (1997) Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 71: 3932-3939.
46. Shih SR, Tsai MC, Tseng SN, Won KF, Shia KS, et al. (2004) Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob Agents Chemother 48: 3523-3529.
47. Gay RT, Belisle S, Beck MA, Meydani SN (2006) An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proc Natl Acad Sci U S A 103: 13825-13830.